Cutaneous Toxicities Associated With Amivantamab in Patients With Non-Small Cell Lung Cancer: A Systematic Review. Koumprentziotis IA, Bakella A, Tsimpidakis A, Stratigos A, et al. Int J Dermatol 2026 Feb 18. doi: 10.1111/ijd.70347.

Read + Share

Amedeo Smart

Independent Medical Education

Koumprentziotis IA, Bakella A, Tsimpidakis A, Stratigos A, et al. Cutaneous Toxicities Associated With Amivantamab in Patients With Non-Small Cell Lung Cancer: A Systematic Review. Int J Dermatol 2026 Feb 18. doi: 10.1111/ijd.70347.
PMID: 41709424